![GlaxoSmithKline / Organofluorides / Respiratory therapy / Pharmacology / Fluticasone propionate / Fluticasone furoate / Rhinitis / Nasal spray / Pharmaceutical drug / Medicine / Pulmonology / Glucocorticoids GlaxoSmithKline / Organofluorides / Respiratory therapy / Pharmacology / Fluticasone propionate / Fluticasone furoate / Rhinitis / Nasal spray / Pharmaceutical drug / Medicine / Pulmonology / Glucocorticoids](https://www.pdfsearch.io/img/dc4c8ac16b184f5b129cdcad6e8be0bc.jpg)
| Document Date: 2013-07-12 14:26:37 Open Document File Size: 72,36 KBShare Result on Facebook
Company GlaxoSmithKline Inc. / FOREWORD Health Canada / Manufacturer/Sponsor GlaxoSmithKline Inc. / Health Canada GlaxoSmithKline Inc. / / Country Canada / / Event FDA Phase / / IndustryTerm proposed manufacturing sites / pharmaceutical development / manufacturing activities / particular product / manufacturing / nervous systems / degradation products / drug product / manufacturing process / food / / MedicalCondition lung eosinophilia model / skin inflammation / delayed type hypersensitivity / seasonal allergic rhinitis / hypersensitivity / inflammation / rhinitis / ear inflammation / lung eosinophilia / / Organization Health Products and Food Branch / / Position General Information Fluticasone furoate / / Product fluticasone propionate / disodium edetate / Avamys / SBD / / PublishedMedium the Health Canada review / / Technology Pharmacokinetics / Pharmacodynamics / /
SocialTag |